We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.00 | 29.09% | 17.75 | 17.00 | 18.50 | 18.25 | 15.25 | 16.25 | 7,554,983 | 16:29:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -2.13 | 46.25M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/10/2022 10:03 | Remember, im here if you need me xx | zeus19 | |
21/10/2022 10:01 | This WILL slide down into the 30s IMO, probably lower after which PURCHASE, AMARETTO and their army will quietly slip away to the next board for daily ramping. CRIMINAL BEHAVIOUR IMO and certainly worth investigating. | antonagis | |
21/10/2022 09:49 | Amaretto, I don't think SK will be bothered about you being disappointed in him 😂. To be fair, you're sometimes as annoying as the ones you're wanting him to kick out. | stevelauren23 | |
21/10/2022 09:33 | SK are u totally incapable of Governing this thread ???I'm really disappointed with you ....Seriously !!! | amaretto1 | |
21/10/2022 08:36 | AN is following his pre planned roll out plan exactly as he said he would from the getgo. The fact that certain posters and holders seem to think that long term Pharma partnerships using a new technology just FDA approved would be signed in three months is a sad reflection of their impatience and inability to read. | purchaseatthetop | |
21/10/2022 08:35 | Nobody was saying that on May 25th you pratt. | jelenko | |
21/10/2022 08:26 | AN has screwed his company and his shareholders which, the latter he openly admitted he didn't care about......fact | jibba jabber |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions